William Kendrick, MD
Nephrology · Greenville, NCNPI 1407858632
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $97,889 of the $125,240 with a category attached, or 78.2%. 39 manufacturers reported payments, led by Amgen at 52.9% of the total. Reporting peaked in 2019 at $47,319 and has fallen 97.9% since, to $1,009 in 2025. Among nephrology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 495 payments — averaging $253.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$66K
- Bayer$23K
- Akebia Therapeutics Inc$16K
- AstraZeneca$16K
- Otsuka America Pharmaceutical, Inc.$469
- Vifor Pharma, Inc.$465
- plus $3K from 33 others
What the payments were for
- Consulting fees$3,8533%
- Speaking & faculty fees$97,88978%
- Travel & lodging$12,53910%
- Food & beverage$10,6519%
- Education$3080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$125,240 in reported general payments places this provider in the 95th percentile of 366 nephrology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 55 | $136,972 |
| FarxigaDapagliflozin Propanediol | 128 | $91,184 |
| KerendiaFinerenone | 90 | $60,738 |
| AuryxiaFerric Citrate | 21 | $33,613 |
| LokelmaSodium Zirconium Cyclosilicate | 23 | $14,138 |
| Cinacalcet Hcl | 28 | $12,578 |
| JardianceEmpagliflozin | 12 | $7,953 |
| Sevelamer Carbonate | 27 | $7,511 |
| Calcium Acetate | 24 | $4,293 |
| Bumetanide | 55 | $2,872 |
| Colchicine | 27 | $2,026 |
| Losartan Potassium | 211 | $1,928 |
| Clonidine | 17 | $1,750 |
| Calcitriol | 44 | $1,621 |
| Febuxostat | 15 | $1,395 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $351 | $136,97255 claims |
| AstraZenecaFarxiga, Lokelma | $16,249 | $105,322151 claims |
| BayerKerendia | $22,564 | $60,73890 claims |
| Akebia Therapeutics IncAuryxia | $16,312 | $33,61321 claims |
| Boehringer IngelheimJardiance | $16 | $7,95312 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $60 | $14114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 366 nephrology providers in North Carolina.
Other nephrology in Greenville
- Richard BlairGreenville$13K
- Anthony ProvenzanoGreenville$11K
- Gregory GreenwoodWinston-Salem$947K
- Michael EtomiCharlotte$212K
- Jason EckelCary$123K
- Raven VooraSanford$111K
- Nam VoAsheville$89K
- Jennifer StoddardPinehurst$77K
- Barry FreedmanWinston Salem$67K
- James McCabeWilmington$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.